This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK), Novavax (NVAX) and Airsculpt Technologies (AIRS)

Tipranks - Tipranks - Mon May 11, 8:44AM CDT

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Shattuck Labs (STTK), Novavax (NVAX) and Airsculpt Technologies (AIRS).

Claim 55% Off TipRanks

Shattuck Labs (STTK)

Citi analyst Yigal Nochomovitz maintained a Hold rating on Shattuck Labs on May 8 and set a price target of $7.00. The company’s shares closed last Friday at $6.85.

According to TipRanks.com, Nochomovitz is a 4-star analyst with an average return of 8.1% and a 43.7% success rate. Nochomovitz covers the Healthcare sector, focusing on stocks such as Ultragenyx Pharmaceutical, ArriVent BioPharma, Inc., and EyePoint Pharmaceuticals. ;'>

Shattuck Labs has an analyst consensus of Strong Buy, with a price target consensus of $13.00, which is a 104.1% upside from current levels. In a report issued on May 5, TipRanks – PerPlexity also reiterated a Hold rating on the stock with a $7.00 price target.

See the top stocks recommended by analysts >>

Novavax (NVAX)

Citi analyst Geoff Meacham maintained a Sell rating on Novavax on May 7 and set a price target of $7.00. The company’s shares closed last Friday at $10.11.

According to TipRanks.com, Meacham is a 5-star analyst with an average return of 10.3% and a 56.4% success rate. Meacham covers the Healthcare sector, focusing on stocks such as Amylyx Pharmaceuticals Inc, Protagonist Therapeutics, and Kiniksa Pharmaceuticals. ;'>

Currently, the analyst consensus on Novavax is a Hold with an average price target of $11.60.

Airsculpt Technologies (AIRS)

In a report issued on May 8, Sam Eiber from BTIG reiterated a Hold rating on Airsculpt Technologies. The company’s shares closed last Friday at $3.86.

According to TipRanks.com, Eiber is a 2-star analyst with an average return of 0.8% and a 29.6% success rate. Eiber covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Merit Medical Systems, and Apyx Medical. ;'>

Airsculpt Technologies has an analyst consensus of Hold.

Read More on STTK:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).